Pharma

Transforming health through business and innovation.

Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers

By

UpdatedOctober 3, 2024

Eli Lilly is building a $4.5 billion factory to speed up drug production

Eli Lilly is building a $4.5 billion factory to speed up drug production

By

PublishedOctober 2, 2024

Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now

Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now

By

PublishedOctober 2, 2024

Drugs like Ozempic are now more popular than insulin for treating diabetes

Drugs like Ozempic are now more popular than insulin for treating diabetes

By

UpdatedOctober 2, 2024

New weight loss drugs could be developed much faster if Roche gets its way

New weight loss drugs could be developed much faster if Roche gets its way

By

PublishedSeptember 30, 2024

The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment

The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment

By

PublishedSeptember 27, 2024

Ozempic could even help prevent opioid overdoses, study says

Ozempic could even help prevent opioid overdoses, study says

By

PublishedSeptember 26, 2024

BioAge Labs wants to raise $200 million in IPO to develop obesity and diabetes drugs

BioAge Labs wants to raise $200 million in IPO to develop obesity and diabetes drugs

PublishedSeptember 25, 2024

Blame drug 'middlemen' for Ozempic and Wegovy prices, Novo Nordisk CEO tells Congress

Blame drug 'middlemen' for Ozempic and Wegovy prices, Novo Nordisk CEO tells Congress

By

UpdatedSeptember 24, 2024

Novo Nordisk's experimental weight loss pill has some concerning side effects

Novo Nordisk's experimental weight loss pill has some concerning side effects

By

UpdatedSeptember 20, 2024

Off-brand Ozempic, Roche stock woes, and Eli Lilly's weekly insulin: Pharma news round up

By

PublishedSeptember 13, 2024

A migraine drug ad featuring Serena Williams got called out by the FDA

A migraine drug ad featuring Serena Williams got called out by the FDA

By

PublishedSeptember 12, 2024

Ozempic maker Novo Nordisk has an experimental anti-obesity pill with noteworthy early trial results

Ozempic maker Novo Nordisk has an experimental anti-obesity pill with noteworthy early trial results

PublishedSeptember 11, 2024

Novo Nordisk's experimental weight loss pill showed significant results in its first trial

Novo Nordisk's experimental weight loss pill showed significant results in its first trial

By

UpdatedSeptember 11, 2024

Eli Lilly's weekly insulin is running into the same issue Novo Nordisk's did

Eli Lilly's weekly insulin is running into the same issue Novo Nordisk's did

By

PublishedSeptember 10, 2024

An experimental weight loss drug’s side effects have Roche stock tumbling

An experimental weight loss drug’s side effects have Roche stock tumbling

By

PublishedSeptember 9, 2024

Abbott just launched a $49 continuous glucose monitor — for people without diabetes

Abbott just launched a $49 continuous glucose monitor — for people without diabetes

By

PublishedSeptember 5, 2024

Eli Lilly says experimental insulin could mean 313 fewer injections per year

Eli Lilly says experimental insulin could mean 313 fewer injections per year

By

PublishedSeptember 5, 2024

A new weight loss drug from an Eli Lily partner targets the elderly

A new weight loss drug from an Eli Lily partner targets the elderly

By

PublishedSeptember 4, 2024

Everything to know about the 10 drugs in the first Medicare price negotiations

Everything to know about the 10 drugs in the first Medicare price negotiations

By

PublishedSeptember 3, 2024

Advertisement